QI LU

Live / Registered — Registered — Section 71 accepted (as of 30 Dec 2021)

What this means for you

Registered since 19 Apr 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Apr 2031: the §71 ten-year affidavit of use).

Record

Serial number
79076475
Registration number
3946913
Mark type
Design + words
Filed
26 Nov 2009
Published for opposition
01 Feb 2011
Registered
19 Apr 2011
Next maintenance filing
§71 ten-year affidavit of use, due by 19 Apr 2031 (grace period to 19 Oct 2031)
Attorney of record
Dana Stewart-Mekdara

Goods and services

  • Class 005 — Pharmaceuticals: [ Pharmaceutical preparations, namely, injections, capsules and tablets for use in ophthalmology, oncology, and chemotherapy; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of inflammation; ] biomedical medicines for use in ophthalmology, oncology and chemotherapy; [ biomedical medicines for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; biomedical medicines for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; biomedical medicines for the treatment of inflammation; ] medicines for humans for use in ophthalmology, oncology and chemotherapy; [ medicines for humans for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; medicines for humans for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; medicines for humans for the treatment of inflammation; ] drugs for medical purposes for use in ophthalmology, oncology and chemotherapy [ ; drugs for medical purposes for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; drugs for medical purposes for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; drugs for medical purposes, namely, the treatment of inflammation ]

Owner

Prosecution history

  • 06 Nov 2022 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 26 Sept 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 26 Sept 2022 — INVALIDATION PROCESSED
  • 30 Aug 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 30 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 30 Dec 2021 — REGISTERED-SEC.71 ACCEPTED
  • 04 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 01 Jun 2021 — TEAS SECTION 71 RECEIVED
  • 10 Dec 2020 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
  • 16 Oct 2020 — CORRECTION TRANSACTION RECEIVED FROM IB
  • 28 Aug 2020 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 19 Apr 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 12 Dec 2019 — INTERNATIONAL REGISTRATION RENEWED
  • 25 Mar 2017 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 25 Mar 2017 — REGISTERED-SEC.71 ACCEPTED

View this trademark record on Rightsy